CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishIntestinal stenosis is one of the most common complications of Crohn’s disease with a prevalence of between 20% and 40% in the small intestine and between 7% and 15% in the colon [1]. Although endoscopic dilatation “throughthe- scope” (TTS) alone or in association with direct injection of steroids and surgery are the current treatments for strictures of the colon, endoscopic dilation represents the initial therapeutic approach for ileo-caecal and ileal strictures and is usually effective for short stenoses [2]. There is currently considerable doubt about the mid- to long-term efficacy of the combination of endoscopic dilatation and direct injection of infliximab [3,4]. We report here our experience of combination therapy with a biological agent, adalimumab, and endoscopic dilatation in a patient with inflammatory strictures of the ileo-caecal valve and ascending colon who had not previously received treatment with a biological agent.
| Titolo: | Adalimumab and endoscopic dilatationin the treatment of inflammatory strictures due to Crohn'diseases: a case report of a treatment – naive patient. | |
| Autori: | ||
| Data di pubblicazione: | 2010 | |
| Rivista: | ||
| Abstract: | Intestinal stenosis is one of the most common complications of Crohn’s disease with a prevalence of between 20% and 40% in the small intestine and between 7% and 15% in the colon [1]. Although endoscopic dilatation “throughthe- scope” (TTS) alone or in association with direct injection of steroids and surgery are the current treatments for strictures of the colon, endoscopic dilation represents the initial therapeutic approach for ileo-caecal and ileal strictures and is usually effective for short stenoses [2]. There is currently considerable doubt about the mid- to long-term efficacy of the combination of endoscopic dilatation and direct injection of infliximab [3,4]. We report here our experience of combination therapy with a biological agent, adalimumab, and endoscopic dilatation in a patient with inflammatory strictures of the ileo-caecal valve and ascending colon who had not previously received treatment with a biological agent. | |
| Handle: | http://hdl.handle.net/11591/186463 | |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Copyright © 2021